Released ready-made European reimbursement reports in March-April 2017

18

May 2017

MTRC is the only European developer of ready-made reimbursement reports for medical technologies. Our reports provide basic reimbursement information (procedure coding, payment mechanism, reimbursement tariffs, policies of payers) in 11 European countries, including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland.

To date, 12 reports have been released:

Are you interested to see what’s inside the reports? Go to the report’s page and order free extract from the report, including the whole section of the report with reimbursement analysis in England.

Reimbursement reports can be purchased either directly from MTRC or from one of our official distribution partners including ReportLinkerMarketResearch.Com and Research and Markets.

The latest related news

24

Apr 2020

The report presents a summary of the reimbursement situation for the use of treatment methods of scoliosis in Europe. The following procedures are considered under the scope of analysis: insertion of the spinal (growing) rod system, anterior or posterior interbody fusion in the spine with or without vertebra resection, sacroiliac joint fusion surgery. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland. It is also possible to add analysis in the Czech Republic, Finland, Hungary, Romania, Russia and Turkey.

Read more

03

Apr 2020

The report presents a summary of the reimbursement situation for minimally invasive treatment of prostate cancer in Europe. The following procedures are considered under the scope of analysis: high intensity focused ultrasound (HIFU), cryoablation, focal laser ablation, radiofrequency ablation, microwave thermal ablation of the prostate. Open and laparoscopic radical prostatectomy, as well as external radioation therapy and low-dose-rate barchytherapy, are considered as comparators. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland. It is also possible to add analysis in the Czech Republic, Finland, Hungary, Romania, Russia and Turkey.

Read more

03

Apr 2020

The report presents a summary of the reimbursement situation for the use of minimally invasive treatment of lung cancer in Europe. The following procedures ware considered under the scope of analysis: cryotherapy, microwave ablation, photodynamic therapy, radiofrequency ablation of lung. Open and VATS lobectomy will be considered as a comparator. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland. It is also possible to add analysis in the Czech Republic, Finland, Hungary, Romania, Russia and Turkey.

Read more

02

Apr 2020

The report presents a summary of the reimbursement situation for occipital nerve stimulation in Europe. The following indications are considered: migraine with aura; cluster headache syndrome. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland. It is also possible to add analysis in the Czech Republic, Finland, Hungary, Romania, Russia and Turkey.

Read more

02

Apr 2020

The report presents a summary of the reimbursement situation for mechanical ventilation in Europe. The following clinical indications are considered: acute community-acquired viral pneumonia complicated with acute respiratory failure; severe sepsis due to acute community-acquired viral pneumonia with multiorgan failure (cardiac, respiratory and renal); acute hemorrhagic stroke with the development of com. The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland. It is also possible to add analysis in the Czech Republic, Finland, Hungary, Romania, Russia and Turkey.

Read more